For general safety background, refer to CDC Safe Injection Practices
Complete a Medical Review Your health history, medications, allergies and relevant safety considerations are reviewed before a plan is recommended
At the time this trial was designed, no study had investigated prolonged high-dose NAC administration during pregnancy, except for a low oral dose NAC (0.6 g/day) trial for up to 20 weeks for recurrent pregnancy loss
Wolverine BPC-157 | TB-500 (Spray) Category Regenerative Research CAS Number N/A Form Factor Nasal Spray Blend Components BPC-157 60 mg CAS: 137525-51-0 TB-500 CAS: 77591-33-4 BPC-157 CAS 137525-51-0 Formula C 62 H 98 N 16 O 22 Molar Mass 1419.5347 g/mol TB-500 CAS 77591-33-4 Formula C 212 H 350 N 56 O 78 S Molar Mass 4963.4421 g/mol This intranasal research formulation combines BPC-157 and TB-500 for the experimental characterization of mucosal transport and systemic biodistribution
Fidalgo M, Ricardo Pires J, Viseu I, Magalhes P, Gregrio H, Afreixo V, et al
Injectable hydrogel composite containing modified gold nanoparticles: implication in bone tissue regeneration